ka<>$H

[kajulie]

The thing about GENE is the share structure, they just did and R/S not long ago, so float is smaller. The projected revenues are huge, like $15 to $20 per share huge. But they are projected. After they report in a few months it will be too late to get in, so it's just a very volatile one to flip right now, but it's definitely worth keeping on watch